Distinguished Visiting Professor (DVP) Lecture Series

Expand All | Collapse All

The Centre has organized a Distinguished Visiting Professors Series with sponsorship acquired through Merck Frosst Canada and Co., Servier and AstraZeneca. Through this series, a forum is provided whereby external experts performing cutting edge research in priority areas are invited to speak and interact with Centre’s members and in turn, the activities of the Centre are profiled to the world’s opinion leaders. The Centre regularly collaborates with University of Toronto Departments and teaching hospitals. Faculty, clinicians, students and visitors are encouraged to attend. To view upcoming speakers, click on the events calendar. To see past speakers, click on one of the years listed below.


Distinguished Visiting Professors: 2017 & 2018

September 14, 2018
Michael J. Ackerman, MD
Professor of Medicine, Pediatrics and Pharmacology, Mayo Clinic
“Secondary Prevention—A Missed Opportunity To Save Lives”

February 26, 2018
Raymond J. Gibbons, MD
Arthur M. and Gladys D. Gray Professor of Medicine, Mayo Clinic
“Seeing in the Dark: Planning Interventions for Peripheral Arterial Disease”

January 22, 2018
Andrew Dueck, MD
Vascular Surgeon and Associate Scientist, Sunnybrook Research Institute
“Seeing in the Dark: Planning Interventions for Peripheral Arterial Disease”

December 1, 2017
David Taggart, MD
Professor of Cardiovascular Surgery, University of Oxford
“The use of randomized cardiovascular surgical trials to DISTORT best clinical practice”

October 16, 2017
Mikhail Kosiborod, MD
Professor of Medicine, University of Missouri-Kansas City School of Medicine
“Current State of Evidence for CV Protection Via Glucose Lowering: SGLT2 Inhibition”

June 29, 2017
Slava Epelman, MD
Assistant Professor of Medicine, University of Toronto
“Primitive Cardiac Macrophages: Role in Tissue Injury, Repair and Regeneration”

June 29, 2017
Phyllis Billia, MD
Assistant Professor, University of Toronto
“Tumor Suppressors in Cardiac Regeneration”

May 9, 2017
Allan Jaffe, MD
Professor of Cardiology and Laboratory Medicine & Pathology, Mayo Clinic
“In Search of Specificity – A Biomarker Odyssey”

April 10, 2017
Matthew Roe, MD
Professor of Medicine, Duke University
“Charting the Path Forward for Pragmatic Trials for Cardiovascular Disease”

March 20, 2017
Matthias G. Friedrich, MD

Professor of Medicine at McGill University and Heidelberg University
“Game Changing Advances in Cardiac MRI”


Distinguished Visiting Professors: 2016

February 17, 2016
Calum MacRae, MD, PhD
Chief of Cardiovascular Medicine, Brigham and Women’s Hospital; Harvard Medical School
“Bridging the gaps in the precision medicine paradigm”

April 6, 2016
Thomas Marwick, MD
Director of Baker IDI Heart and Diabetes Institute
Former Director of the Menzies Research Institute at the University of Tasmania
“The A to B of Heart Failure”

May 30, 2016
VM Christoffels, MD
Professor of Developmental Biology, University of Amsterdam
“Transcriptional Regulation of Cardiac Electrical Patterning”

September 6, 2016
W. H. Wilson Tang, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine at CWRU
“Cardio-Renal Syndrome: Past, Present, and Future”

October 17, 2016
David Brieger, MD

Professor of Cardiology, University of Sydney
“Risk Aversion in Cardiology Practice: Insights from Clinical Quality Registries”

November 7, 2016
Chris Gale, MD

Associate Professor of Cardiovascular Health Sciences, University of Leeds
“Higher Resolution Insights into Acute Myocardial Infarction Care and Outcomes: #datasavelives”

December 9, 2016
Osama Hamdy, MD

Assistant Professor of Medicine at Harvard Medical School
“Long-term Lifestyle Intervention and Cardiovascular Risk Factors: What We Know”


Distinguished Visiting Professors: 2015

Joseph Hill, MD, PhD., Professor of Internal Medicine and Molecular Biology and Chief, Division of Cardiology at the University of Texas Southwestern Medical Center
“Cardioprotection: Tale of Two Mechanisms”
January 26, 2015

Jacques Genest, M.D., Professor, Faculty of Medicine; Novartis Chair in Medicine, McGill University
“Systems and Molecular Approaches to Severe Hyperlipidemias (SMASH)”
March 2, 2015

Garret FitzGerald, M.D., McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania, Chair of the Department of Pharmacology and Director of the Institute for Translational Medicine and Therapeutics
“Adventures with Peripheral Clocks”
March 26, 2015

Eduardo Marbán, MD, PhD, Director, Cedars-Sinai Heart Institute
“Therapeutic Regeneration of the “Irreversibly” Injured Human Heart”
May 11, 2015

André La Gerche, MBBS, PhD, Head of Sports Cardiology at the Baker IDI Heart and Diabetes Institute Melbourne
“Identifying (the few) Endurance Athletes at Risk of Arrhythmias”
May 19, 2015

Robin Choudhury, MA, DM, Professor of Cardiovascular Medicine, Clinical Director Oxford Acute Vascular Imaging Centre Radcliffe Department of Medicine, University of Oxford
“Characterisation of the Monocyte Response in Acute Myocardial Infarction – Insights from Transcriptomic Studies in Mice and Men”
September 21, 2015

Darren McGuire, MD, MHSc, Professor of Medicine; Dallas Heart Ball Chair for Research on Heart Disease in Women
“Cardiovascular Assessment of Diabetes Drugs: Selected Lessons Learned Thus Far”
October 19, 2015

Peter Backx, MD, Professor, Departments of Physiology and Medicine, University of Toronto; Director, Transgenic Physiology Laboratory
“Links Between Endurance Exercise and Atrial Fibrillation: What Every Sports Buff Should Know”
December 7, 2015


Distinguished visiting professors 2014

Joao Lima, MD Professor of Medicine and Radiology, Director of Cardiovascular Imaging at Johns Hopkins Hospital
Title: Myocardial Fibrosis in Incident Heart Failure in the US: Lessons from MESA
January 13, 2014

Justin Ezekowitz, MD Associate Professor of Medicine in the Division of Cardiology at the University of Alberta
Title: Acute Heart Failure: Risk and Endpoints
January 27, 2014

Deepak Bhatt, MD, MPH Professor of Medicine at Harvard Medical School
Title: Advances in Antiplatelet Therapy
February 20, 2014

Robert Giugliano, MD Senior Investigator at TIMI Study Group; and Associate Professor of Medicine at Harvard Medical School
Title: Target Specific Oral Anticoagulants for Atrial Fibrillation
March 25, 2014

Euan Ashley, MD Associate Professor of Medicine (Cardiovascular), of Genetics and of Pathology at the Stanford University Medical Center
Title: Six Degrees: Networks, Systems and Therapeutics in Cardiovascular Biology
April 28, 2014

Stefan D. Anker, MD Professor of Innovative Clinical Trials (Cardiology & Cachexia Research) University Medical Center Göttingen (UMG), Göttingen, Germany
Title: Co-morbidities in Heart Failure: Update on Cachexia & Iron Deficiency
November 12, 2014

Vivek Rao, MD Chief of Cardiovascular Surgery, Munk Professor in Advanced Cardiac Therapeutics at Peter Munk Cardiac Centre, and Professor of Surgery at the University of Toronto
Title: Translational Concepts in Regenerative Medicine: Pitfalls with Innovation
December 1, 2014


Distinguished visiting professors 2013

Denisa Wagner, PhD Department of Pathology, Harvard Medical School
Title: NETs: Linking Inflammation and Thrombosis
January 14, 2013

David Hood, PhD Professor, York University
Title: Molecular mechanisms of mitochondrial adaptations in aged skeletal muscle
February 11, 2013

Kai C. Wollert Professor of Molecular and Translational Cardiology, Hans-Borst Center for Heart & Stem Cell Research
Title: Paracrine signaling in the heart: novel players and emerging clinical applications
March 4, 2013

Pieter de Tombe, PhD James R. DePauw Professor of Cell and Molecular Physiology, Co-Director, Cardiovascular Research Institute, Loyola University
Title: Myocardial Sarcomere Dynamics in Health and Disease
April 3, 2013

Paul Armstrong, MD Professor of Medicine, University of Alberta
Title: Lessons Learned and Roads Untraveled; Perspectives of a Clinical Investigator
April 29, 2013

Keith A Fox, MD Professor of Medicine, University of Edinburgh
Title: Acute Coronary Syndrome: Have we reached the limits?
May 6, 2013

Arie Horowitz, D.Sc. Assistant Professor, Department of Molecular Cardiology Lerner Research Institute, Cleveland Clinic Foundation
Title: Exploiting membrane traffic for targeting angiogenesis
June 10, 2013

Duncan Stewart, MD CEO and Scientific Director of the Ottawa Hospital Research Institute, Vice-President of Research at the Ottawa Hospital and Professor of Medicine at the University of Ottawa
Title: Cell therapies for cardiovascular disease – version 2.0
September 30, 2013

Naveen Pereira, MD Assistant Professor of Medicine; Division of Cardiovascular Diseases, Mayo Clinic
Title: Clopidogrel Pharmacogenetics: Can We Impact Clinical Practice?
October 15, 2013

David Alan Kass, MD Director of the Johns Hopkins Center for Molecular Cardiovascular Biology and Professor of Medicine, Biomedical Engineering and Cellular and Molecular Medicine, John Hopkins University
Title: Reverse Engineering Cardiac Resynchronization
November 4, 2013

Mansoor Husain, MD Director of the Toronto General Research Institute, Professor of Medicine, Physiology, and Laboratory Medicine and Pathiobiology and former Director of the Heart & Stroke/Richard Lewar Centre of Excellence.
Title: Molecular studies of cardiovascular disease: Toronto-style
December 16, 2013


Distinguished visiting professors 2012

Toren Finkel, MD, PhD Chief, Center for Molecular Medicine, National Heart, Lung, and Blood Institute NIH Adjunct Associate Professor of Medicine, Johns Hopkins School of Medicine
Title: How understanding the mechanisms of aging can lead to new therapies for cardiovascular disease
January 23, 2012

Mikhail Kosiborod, MD, FACC, FAHA Training Program Director, American Heart Association Outcomes Research Postdoctoral Fellowship, Mid America Heart Institute of Saint-Luke’s Hospital, Kansas City Clinical Scholar, Mid America Heart Institute/Saint Luke’s Hospital, Kansas City Associate Professor, University of Missouri – Kansas City School of Medicine, Kansas City
Title: Blood Glucose in Acute MI: Trials, Tribulations and Future Directions
February 13, 2012

John S. Ikonomidis, MD, PhD, FRCS(C), FACS, FAHA, FACC Horace G. Smithy Professor, Chief, Division of Cardiothoracic Surgery Director, South Carolina Heart Valve Center Director, Heart and Vascular Service Line Medical University of South Carolina
Title: Proteinase Systems and Thoracic Aortic Aneurysm Progression
March 26, 2012

Jeff Robbins, PhD, FAHA Professor, Department of Pediatrics & Director, Division of Molecular Cardiovascular Biology, Associate Chair, Children’s Hospital Research Foundation Executive Co-Director, The Heart Institute, Cincinnati Children’s Hospital Medical Center
Title: Proteotoxicity and Cardiac Disease
April 30, 2012

Philippe Menasche, MD, PhD Professor of Thoracic and Cardiovascular Surgery, University Paris Descartes, Director, Heart Failure Surgical Unit, Hôpital Européan George Pompidou, Paris
Title: Pluripotent stem cell engraftment to enhance ventricular function
June 25, 2012

Ronald Li, PhD Director, Stem Cell and Regenerative Medicine Consortium, Li Ka Shing Faculty of Medicine, University of Hong Kong, Professor of Medicine and Physiology, University of Hong Kong
Title: Cell- and Gene-based Approaches for Engineering Bio-artificial Human Heart Cells and Tissues: How close are we?
October 1, 2012

William McKenna, MD Professor of Cardiology, Institute of Cardiovascular Science, University College London, Director Inherited Cardiovascular Disease, The Heart Hospital
Title: Arrhythmogenesis in Desmosomal Disease
October 15, 2012


Distinguished visiting professors 2011

Jean-Claude Tardif, MD Director, MHI Research Center Professor of Medicine, Université de Montréal Endowed Research Chair in Atherosclerosis Montreal Heart Institute, Université de Montréal
Title: Pivotal Role of Heart Rate in Atherosclerosis
January 24, 2011

Rob Beanlands, MD Chief, Cardiac Imaging Director, Cardiac PET Centre Professor of Medicine (Cardiology)/Radiology (Cross-Appointment) Division of Cardiology – University of Ottawa Heart Institute
Title: Imaging in Heart Failure: The Big Picture
April 18, 2011

Randy Seeley, PhD Donald C. Harrison Endowed Chair, Professor, Director of the Cincinnati Diabetes and Obesity Center, Director of the Obesity Research Center. University of Cincinnati.
Title: How obesity goes to our heads: Unique aspects of CNS regulation of food intake and body weight
May 09, 2011

Thomas Force, MD James C. Wilson Professor of Medicine, Thomas Jefferson University, Philadelphia Clinical Director, Center for Translational Medicine, Jefferson Medical College
Title: Protein Kinases in the Heart: Targets old and new regulating injury and repair
September 26, 2011


Distinguished visiting professors 2010

Aly Karsan, MD, BC Cancer Research Centre, Vancouver, Canada Senior Scientist, Medical Biophysics, BC Cancer Agency. Professor of Pathology, University of British Columbia. Health Research Scholar – Michael Smith Foundation for Health Research. CIHR Clinician-Scientist (1993-2003).
Title: The Role of Notch in Mesenchymal Transformation
January 18, 2010

Jason Dyck, PhD, Edmonton, Alberta Professor and Director Cardiovascular Research Centre Canada Research Chair in Molecular Biology of Heart Disease and Metabolism AHFMR Senior Scholar, Department of Pediatrics, University of Alberta
Title: Molecular signalling pathways involved in the regulation of cardiac hypertrophy
February 1, 2010

Derek Yellon, University College London Hospital & Medical School Director of the Hatter Cardiovascular Institute & Head of the Research Department of Cardiovascular Medicine
Title: Protecting the heart from ischaemia/reperfusion injury: from laboratory bench to hospital bedside
March 1, 2010

Geoff Pickering, MD, PhD London, Ontario Professor, Departments of Medicine, Biochemistry, and Medical Biophysics Robart Research, University of Western Ontario
Title: Stabilizing the vulnerable vasculature
April 12 2010

Martin Bennett, PhD Cambridge, UK BHF Professor of Cardiovascular Sciences/ Honorary Consultant Cardiologist Division of Cardiovascular Medicine Addenbrooke’s Centre for Clinical Investigation,
Title: The role and origin of smooth muscle cells in atherosclerosis
May 3, 2010

Stefan Offermanns, PhD, Heidelberg, Germany Director, Professor of Pharmacology, Institute of Pharmacology. University of Heidelberg
Title: G-protein-mediated signaling in cardiovascular physiology and pathology
May 31, 2010

Hartmut Weiler, PhD Senior Investigator,Blood Research Institute, Blood Center of Wisconsin Assistant Professor, Department of Physiology, Medical College of Wisconsin Director, Transgenic Core, Medical College of Wisconsin
Title: Anticoagulant responses to injury – Biology of the Thrombomodulin-protein C system
October 4, 2010

Edward O’Brien, MD Professor of Medicine (Cardiology) Research Chair (Canadian Institutes of Health Research / Medtronic) University of Ottawa Heart Institute
Title: Heat Shock Protein 27 – A Novel Anti-atherogenesis Factor
November 1, 2010

Michael Rosen, MD New York Gustavus A. Pfeiffer Professor of Pharmacology Professor of Pediatrics Director, Center for Molecular Therapeutics Columbia University
Title: Why T waves change… Exploring the links between signals and responses
November 8, 2010


Distinguished visiting professors 2009

Heinrich Taegtmeyer, MD, PhD University of Texas Health Sciences Centre at Houston
Title: Too Much of a Good Thing – Insulin Resistance and the Heart
January 26, 2009

Don Maurice, PhD Queen’s University
Title: Compartment-Specific Cellular Cyclic Nucleotide Signaling – No Longer the Last Refuge of Scoundrels
March 30, 2009

Stanley Nattel, MD, University of Montreal, Montreal Heart Institute
Title: Molecular Determinants of Atrial Fibrillation
April 20, 2009

Todd Anderson, MD, University of Calgary
Title: The Prognostic Significance of Endothelial Dysfunction
May 4, 2009

Ira Goldberg, MD, Columbia University
Title: Correcting Lipotoxicity
May 18, 2009

Peng-Sheng Chen, MD, Indiana University School of Medicine
Title: The Initiation of the Heart Beat
September 21, 2009


Distinguished visiting professors 2008

Dr. Gary Lopaschuk, Scientific Director, Mazankowski Alberta Heart Institute; Professor, Department of Pediatrics and Adjunct Professor, Department of Pharmacology,Faculty of Medicine & Dentistry, University of Alberta
Title: Optimizing cardiac energy metabolism as an approach to treating ischemic heart disease and heart failure
January 14, 2008

Dr. Richard Schulz, Professor, Departments of Pediatrics and Pharmacology University of Alberta
Title: MicroRNA Regulation of Cardiac Development and Disease
April 28th, 2008

Dr. David Gutterman, Northwestern Mutual Professor of Cardiology, Senior Associate Dean for Research Medical College of Wisconsin
Title: Flow-induced vasodilation in the human heart – from endothelial mechanisms to clinical implications
May 26, 2008

Dr. Paul Kubes, Professor, Departments of Physiology & Biophysics and Medicine Director, Calvin, Phoebe & Joan Snyder Institute of Infection, Immunity and Inflammation University of Calgary Health Sciences Centre
Title: Mechanisms of leukocyte recruitment in inflammation
June 9, 2008

Dr. Donald Bers, Professor and Chairman, Department of Physiology Loyola University Chicago, Stritch School of Medicine
Title: Ca and CaMKII in Heart Failure – E-C Coupling, Arrhythmogenesis & Transcriptional Regulation
February 25, 2008


Distinguished visiting professors 2007

Dr. Michael Gollob, Cardiac Electrophysiologist, University of Ottawa Heart Institute Assistant Professor, Division of Cardiology, Department of Medicine, University of Ottawa
Title: The Genetic Basis of Cardiac Arrhythmias
February 19, 2007

Dr. William Sessa, Professor of Pharmacology, Yale University School of Medicine, Vice Chairman, Department of Pharmacology, Deputy Director, Vascular Biology & Transplantation Program
Title: Novel mechanisms of angiogenesis and vascular remodeling – Insights from proteomics
April 16, 2007

Dr. Daniel P. Kelly, Professor of Medicine and Molecular Biology & Pharmacology Center for Cardiovascular Research Washington University School of Medicine St. Louis, MO
Title: Nuclear receptor signaling in the normal and failing heart
May 3, 2007

Dr. Avril V. Somlyo, Professor of Molecular Physiology and Biological Physics, Professor of Pathology, University of Virginia School of Medicine, Charlottesville
Title: Signaling from membranes to crossbridges in smooth muscle and a novel role for N-cadherin in conduction in the heart
June 4, 2007

Dr. Bruce McManus, MD, PhD, Professor in the Department of Pathology and Laboratory Medicine, University of British Columbia, Director of the iCAPTURE Centre and Scientifc Director of the Heart Centre at Providence Health Care
Title: Predictive and Diagnostic Biomarkers in Transplantation
September 24, 2007

Dr. David Beech, PhD, Professor of Molecular and Cellular Physiology, Institute of Membrane & Systems Biology, Faculty of Biological Sciences, University of Leeds
Title: Ion Channel Switching and Activation in Occlusive Vascular Disease
October 1, 2007

Dr. Mordecai Blaustein, MD, Professor, Department of Physiology Director, Maryland Center for Heart, Hypertension and Kidney Disease
Title: Salt licks and salt tricks. How salt retention causes hypertension
November 12, 2007


Distinguished visiting professors 2006

Dr. Ed Yeh, MD Chair of Cardiology M.D. Anderson Cancer Center Director, Research Center for Cardiovascular Diseases University of Texas Health Science Center Houston, TX U.S.A.
Title: To Mend a Broken Heart – Stem Cell for Myocardial Regeneration
February 27, 2006

Dr. Charles Murry, MD, PhD Professor of Pathology Director, Centre for Cardiovascular Biology and Regenerative Medicine University of Washington Seattle, WA
Title: Stem Cell Therapy for the Infarcted Heart
April 03, 2006

Dr. Ron Victor, Professor and Chief, Internal Medicine -Hypertension Division Graduate School of Biomedical Science UT Southwestern Medical Center at Dallas
Title: Functional Ischemia as a cause of Duchenne Muscular Dystrophy – From Bench to Bedside and Back and Forth
April 24, 2006

Dr. Joseph Loscalzo, Hersey Professor of the Theory and Practice of Medicine, Harvard Medical School; Chairman, Department of Medicine; Physician-in-Chief, Brigham and Women’s Hospital Boston, Massachusetts
Title: Homocysteine and Atherothrombosis – Mechanisms, Controversies, and Future Directions
October 30, 2006

Dr. Lorrie A. Kirshenbaum, Professor Departments of Physiology and Pharmacology & Therapeutics, Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Canada Research Chair in Molecular Cardiology
Title: “Molecular Regulators of Apoptosis” – Cross Roads Where Life Meets Death
November 20, 2006

Dr. Kenneth Walsh, Ph.D. Professor of Medicine Head, Molecular Cardiology Whitaker Cardiovascular Institute Boston University School of Medicine
Title: Molecular Regulators of Apoptosis: Cross Roads Where Life Meets Death
December 04, 2006


Distinguished visiting professors 2005

Dr. Rick Moss, Chair, Department of Physiology University of Wisconsin Madison, WI U.S.A.
Title: The Paradox of Hyper-Contractility and Cardiac Insufficiency – Insights from the cMyBP-C Null Mouse
November 21, 2005

Dr. Jean-Claude Tardif, MD, Associate Professor, Department of Medicine, Director, Montreal Heart Institute Research Centre, Pfizer and CIHR Chair in Atherosclerosis, Montreal, PQ
Title: Regression of Atherosclerosis and of Related Clinical Events
May 02, 2005

Dr. Jagut Narula, MD, PhD, Associate Dean, College of Medicine, Chief of Cardiology, and Professor of Medicine, University of California, Irvine, Irvine, CA
Title: Novel Imaging of Myocardial Remodeling and Heart Failure
April 18, 2005

Ralph A. Kelly, Vice President, Clinical Affairs – Genzyme Corporation, Framingham, MA
Title: Targeting the Tissue Response to Hypoxia – Therapeutic Angiogenesis with a Constitutively Active HIF-1a Transgene
April 04, 2005

Dr. Gordon F. Tomaselli, MD, Professor of Medicine, Division of Cardiology & Molecular Medicine; Vice-Chair of Research, Department of Medicine, Johns Hopkins University, Baltimore, MD
Title: Electrical Remodeling in the Failing Heart – Implications for Sudden Cardiac Death
February 28, 2005

Dr. Evangelos Michelakis, Associate Professor of Medicine & Director of the Pulmonary Hypertension Program, University of Alberta.
Title: Mitochondria at the Crossroads of Vascular Disease and Cancer – Novel Therapeutic Approaches
January 31, 2005

Dr. Steven R. Houser, PhD, Laura H. Carnell Professor of Physiology. Director, Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA
Title: Mechanisms for Depressed Contractility in Heart Failure – How Can We Fix Them?
January 17, 2005


Distinguished visiting professors 2004

Dr. Murray W. Huff, PhD, Professor, Department of Medicine & Endocrinology, Director, Vascular Biology Group, Robarts Research Institute, University of Western Ontario, London, Ontario
Title: Novel targets for the regulation of hepatic cholesterol homeostasis – Impact on the kinetics of apoB100 metabolism in vivo
November 22, 2004

Dr. Alvin H. Schmaier, MD, Professor of Internal Medicine & Pathology, Director, Coagulation Laboratory, University of Michigan, Ann Arbor, MI
Title: Linking Blood Pressure Control with Thrombosis; A Novel Interaction Between the Plasma Kallikrein/Kinin and Renin Angiotensin Systems
October 18, 2004

Dr. Eric Peterson, Associate Professor of Medicine, Director of CV Outcomes Research & Quality, Duke University Medical Center, Durham, NC
Title: CQI in Cardiac Care – Ending Business as Usual
May 31, 2004

Dr. Robert Califf, Professor of Medicine, Associate Vice Chancellor for Clinical Research, Director, Duke Clinical Research Institute, Durham, NC
Title: The Heart Failure Quartet – 4 Large Trials in Heart Failure Populations
April 26, 2004

Dr. Jeffery D. Molkentin, PhD, Associate Professor, Children’s Hospital Medical Center, Molecular Cardiovascular Biology, Cincinnati, OH
Title: PKCalpha – A Novel Regulator of Cardiac Contractility and Heart Failure
April 05, 2004

Dr. E. Dale Abel, MD, PhD, Assistant Professor of Medicine & Biochemistry, Division of Endocrinology, Diabetes and Metabolism, University of Utah, School of Medicine, Salt Lake City, Utah
Title: Myocardial Insulin Resistance and Cardiac Dysfunction in Obesity and Diabetes
February 09, 2004

Dr. Stephen L. Archer, Professor of Medicine & Physiology, Director, Division of Cardiology, Heart & Stroke Chair in Cardiovascular Research, University of Alberta, Edmonton, AB
Title: Everything You Wanted To Know About Potassium Channels; But We’re Afraid To Ask
January 12, 2004


Distinguished visiting professors 2003

Dr. Karl T. Weber, MD, Neuton Stern Professor of Cardiovascular Medicine, Director, Division of Cardiovascular Diseases, University of Tennessee Health Sciences Center, Memphis, Tennessee
Title: Aldosteronism – A New Perspective on the Neuroendocrine-Immune Interface
November 03, 2003

Dr. Richard Theodore Lee, Associate Professor of Medicine, Harvard Medical School, Cambridge, MA
Title: Liquid Heart: Injectable Microenvironments for Cardiac Regeneration
October 20, 2003

Dr. Michael Schneider, Professor, Centre for Cardiovascular Development, Baylor College of Medicine, Houston, TX
Title: Cardiac progenitor cells from adult myocardium – Homing, differentiation, and fusion following infarction
September 29, 2003

Dr. Peter Paré, Professor, Department of Medicine, University of British Columbia, Vancouver, B.C.
Title: Finding susceptibility Genes for Complex Genetic Pulmonary and Cardiovascular Disease
March 24, 2003

Dr. Kenneth Chien, Professor, University of California at San Diego Department of Medicine and the Salk Institute, San Diego, CA
Title: Genotype, Phenotype: Upstairs, downstairs in the family of cardiomyopathies
March 03, 2003

Dr. Scott Heximer, Assistant Professor, Department of Physiology and Heart & Stroke/Richard Lewar Centre of Excellence, University of Toronto, Toronto
Title: Hypertension and Prolonged Vasoconstrictor Signaling in RGS-2 Deficient Mice
January 27, 2003


Distinguished visiting professors 2002

Dr. Josef Penninger, Staff Scientist Amgen Institute Ontario Cancer Institute/Princess Margaret Hospital, Associate Professor, Departments of Immunology and Medical Biophysics University of Toronto, Associate Professor, Department of Experimental Pathology University of Innsbruck, Austria.
Title: Control of Heart Size and Heart Function by P13K Signaling
November 04, 2002

Dr. Joshua M. Hare, MD, Associate Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
Title: The use of stem cells in the repair of myocardial infarction
September 30, 2002

Dr. Marlene Rabinovitch, M.D., F.R.C.P.(C)., F.A.C.C., HSFO Endowed Research Chair, Professor of Pediatrics, Medicine, Laboratory Medicine & Pathobiology, University of Toronto, Director, Cardiovascular Research Program, The Hospital for Sick Children
Title: The Ductus Arteriosus and Gene Regulation
June 17, 2002

Dr. Janet Rossant, Professor of Molecular & Medical Genetics and Obstetrics & Gynecology, University of Toronto, Joint Head, Program in Development and Fetal Health,Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario
Title: Mouse Mutagenesis – Models of Human Disease
April 22, 2002

Dr. Mark L. Entman, Professor of Medicine and Biochemistry, Chief, Cardiovascular Sciences Section, Department of Medicine, Scientific Director, The DeBakey Heart Center, Baylor College of Medicine, Houston, Texas
Title: Inflammation in Cardiac Protection and Repair
March 25, 2002


Distinguished visiting professors 2001

Dr. Carlos M. Ferrario, Professor of Physiology and Pharmacology, Director, The Hypertension and Vascular Disease Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina
Title: The Renin Antiotensin System – A Link to the Pathogenesis of Atherosclerosis
November 26, 2001

Dr. Simon Pimstone, MD, PhD, FRCPC, Founder and Vice President, Clinical and Medical Affairs, Xenon Genetics Inc.
Title: Treating Common Human Disease – Insights from Rare Genetic Disorders
October 29, 2001

Dr. Jennifer E. Van Eyk, Assistant Professor, Department of Physiology, Queen’s University
Title: Proteomics: In Search for the Proteins that Cause Heart Disease
September 24, 2001

Dr. Mark W. Majesky, Associate Professor, Department of Pathology, Center for Cardiovascular Development Baylor College of Medicine, Texas A&M University, Houston, Texas
Title: Molecular Pathways Controlling Coronary Smooth Muscle Differentiation from Proepicardial Cells
April 23, 2001

Dr. Thomas N. Wight, Affiliate Professor of Pathology, University of Washington, and Chair, Vascular Biology, Hope Heart Institute, Seattle, Washington
Title: Proteoglycans and Hyaluronan are Extracellular Matrix Molecules that Regulate Key Events in Atherosclerosis and Restenosis.
March 26, 2001

Dr. Joseph Metzger, PhD, Associate Professor of Physiology and Internal Medicine, The University of Michigan Medical School
Title: Genetic Engineering in the Heart by Transgenesis and DNA-Virus Gene Transfer
February 12, 2001


Distinguished visiting professors 2000

Dr. Pavel Hamet, Professor,. Departments of Medicine, Physiology and Nutrition, University of Montreal; Director of Research, Research centre of the Centre Hospitalier de l’Universite de Montreal (CHUM).
Title: Chasing the Genes of Hypertension
November 20, 2000

Dr. Barbara J. Deal, Professor of Pediatrics Northwestern University Medical School, Clinical Associate Professor of Pediatrics, University of Wisconsin Children’s Hospital.
Title: Novel Approaches to the Management of Arrhythmias in Complex Congenital Disease in the Adult
October 16, 2000

Dr. Robert Hegele, Professor of Medicine and Biochemistry, Robarts Research Institute, University of Western Ontario.
Title: Genetic Studies of Atherosclerosis in Canadian Sub-Populations
September 18, 2000

Dr. Jonathan Epstein, Assistant Professor of Medicine, Hospital of the University of Pennsylvania
Title: Role of Pax3 in Muscle and Cardiac Development
June 28, 2000

Dr. Paul Kubes, Professor, Departments of Physiology, Biophysics and Medicine, University of Calgary Health Sciences Centre
Title: The Cardiovascular System and the Inflammatory Response – Use of Knockout Mice
May 15, 2000

Dr. David A. Dichek, Associate Investigator of the Gladstone Institute of Cardiovascular Disease, Associate Professor of Medicine, UCSF
Title: Vascular Gene Transfer – New Biology and New Technology
May 1, 2000

Dr. Bjorne Dahlof, Associate Professor of Medicine, Director Clinical Trial Unit, Sahlgrenski University Hospital/Ostra Goteborg University
Title: Importance of Treating Hypertension – Current and Future Treatment Options
April 18, 2000

Dr. Salim Yusuf, Professor of Medicine, Head Division of Cardiology, McMaster University
Title: The Global Burden of Cardiovascular Disease
April 17, 2000

Dr. Michael Zile, Professor of Medicine, Medical University of South Carolina Heart Centre
Title: Diastolic Heart Failure – Cellular and Extracellular Mechanisms
April 10, 2000

Dr. Randy Chitwood , Cardiothoracic Surgeon, Brody School of Medicine, East Carolina University
Title: Videoscopic and Robotic Mitral Valve Surgery at Dawn of the New Millennium
February 25, 2000

Dr. John Burnett, Professor of Medicine Mayo Clinic
Title: Vasopeptidase Inhibition – A New Target in Cardiovascular Disease
January 14, 2000


Distinguished visiting professors 1999

Dr. Stephen Schwartz, Professor of Pathology, University of Washington
Title: Origins of the Aortic Intima: Soil for Atherosclerosis
December 9, 1999

Dr. Jeffery Molkentin, Assistant Professor of Pediatrics, University of Cincinnati, Children’s Hospital Medical Centre
Title: Intracellular Signaling Pathways that Regulate Cardiac Hypertrophy – Role of Calcineruin/NFAT3
October 28, 1999

Dr. Deepak Srivastava, Assistant Professor of Pediatrics, University of Texas Southewestern Medical Centre
Title: The Molecular Basis of Cardiac Development and Congenital Heart Disease
October 7, 1999

Dr. Eduardo Marban, Professor of Medicine and Physiology, Johns Hopkins University Modification of Neuronal and Cardiac Excitability by Ion Channel
Title: Gene Transfer – First Step Towards Gene Therapy of Excitability Disorders
September 21, 1999

wp_adminDistinguished Visiting Professor (DVP) Lecture Series